[28P2-am1-102S] Effects of permeation enhancers on in vitro permeation of atomoxetine in its tape formulation

○Naoto Suzuki¹, Yasuharu Kashiwagura¹, Kai Saito¹, Motoyasu Miura¹, Rakan Matsui¹, Shinya Uchida¹ (1. Sch. Pharm. Sci., Univ. Shizuoka)

[28P2-am1-103] Pilot Study for Development of Systemic-Acting GHK-Cu Preparation (2) Biological Sample Analysis

○Ken-ichi Ohno¹, Sakurako Nakamura¹, Daiki Watanabe¹, Rina Kosakai¹, Kenta Yamamoto¹, Satoshi Takamatsu¹, Masayoshi Koinuma¹ (1. Dept. Pharm. Sci., Teikyo Heisei Univ.)

[28P2-am1-104] Chemical stability after mixing continuous infusion drugs used to treat cardiogenic shock

○Toshihisa Onoda¹, Masako Kinoshita¹, Hiroyuki Tanaka¹, Kaori Izawa², Atsushi Urano², Naoko Sato², Masayuki Masuda², Toshihiro Ishii¹ (1. Grad. Sch. Pharm. Sci., Toho Univ., 2. Dept. Pharm., Toho Univ. Sakura Medical Center)

[28P2-am1-105S] Inhibitory effect of S-PRG eluate on Streptcoccus mutans growth and biofilm formation

○Jyoma Ito¹, Himawari Kimura¹, Yoichi Yamada², Eiichi Toorisaka³, Akari Kawanaka¹, Humina Yano¹, Hiroshige Ono¹ (1. Sanyo-Onoda City University, 2. Shuujitsu University, 3. Yamaguchi University)

[28P2-am1-106S] Changes of drug elution behavior from tablets with food thickening agents

○Nanako Ueda¹, Rena Kako¹, Tetsuya Shimoyama¹, Kunihiko Itoh¹, Michiya Kobayashi¹ (1. Sch. of Pharm. Sci., Health Sci. Univ. of Hokkaido)

[28P2-am1-107] Compatibility of Clopidogrel Sulfate and Quetiapine Fumarate in ground mixture

○Yuichiro Tomisawa¹, Yuki Nakao¹, Shinya Abe², Hikaru Matsui², Noriyuki Konno¹, Daisuke Tateishi², Shouko Yoshimachi², Kazuhiko Nomura² (1. Tsuruha Pharmacies Co., Ltd., 2. Tsuruha Holdings Inc.)

[28P2-am1-108] Study on physical properties and taste masking effect of Jelly for facilitating drug administration.

○Misuzu Ota¹, Rikako Kurihara², Atsushi Hasegawa¹, Isao Saito¹, Yasuko Obata², Yuri Ikeuchi Takahashi² (1. Sanno Hospital, 2. Hoshi Univ.)

[28P2-am1-109] Approaches to safe dispensing and improving pharmaceutical patient care ( 1 ) ~ Construction of a safety dispensing information sharing systems ~

○Makiko Kanehara¹, Takashi Usui¹ (1. FRONTIER CO.,LTD)

[28P2-am1-110] Approaches to safe dispensing and improving pharmaceutical patient care ( 2 ) ~ Aggregation and evaluation of a safety dispensing information sharing system ~

○Takashi Usui¹, Makiko Kanehara¹ (1. FRONTIER CO.,LTD)

[28P2-am1-111] Regardinig the case of changing to another device and proporsing a prescription due to shipping restrictions on infusion pump equipment

○Hatsune Yamashita¹, Masako Tanaka¹, Tomomi Sugita¹, Yuka Yamada¹, Yasuhiro Hosokawa¹ (1. Kraft Inc. Sakura Pharmacy)

[28P2-am1-112] Environmental contamination and assessment of exposure to antineoplastic agents after long-term use of pharmaceutical safety cabinet with ozone decontamination

○Mari Saito¹, Rena Nishigaki¹, Kimihiko Sato¹, Toshihisa Nakashima¹, Yuko Yamamoto², Kouzo Tamura³, Kentaro Fujii², Mitsunobu Ishikawa¹, Yoshimasa Saito¹, Toru Akagi¹, Hironobu Hashimoto¹, Tetsuya Furukawa¹ (1. Department of Pharmacy , National Cancer Center Hospital, 2. BIOZONE MEDICAL Co., LTD., 3. TAMURATECO Co., LTD.)

[28P2-am1-113] Research for new cleaning agents for automatic dividing packaging machines

○Sayuri Maruo¹, Tadakazu Tokumura^1,2, Yuko Miyamoto³ (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 2. Small Village, 3. Mitsubishi Chemical)

[28P2-am1-114] Ability of a new cleaning agent for automatic dividing packaging machines

○Tadakazu Tokumura^1,2, Sayuri Maruo², Yuko Miyamoto³ (1. Small Village, 2. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 3. Mitsubishi Chemical )

[28P2-am1-115S] Experiment study about over time for compounding equal volume mixture of Steroid ointment/crem and Hirudiod soft ointment using planetary centrifugal mixer

○Kirika Onaka¹, Hinako Takahashi¹, Anna Kiyomi¹, Shinobu Imai², Munetoshi Sugiura¹, Haruka Manabe³, Mika Matsumoto⁴, Michiteru Ohtani⁴, Taro Ikuta⁵, Naoya Okamoto⁵ (1. Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2. Division of Pharmacoepidemiology, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, 3. Department of Hospital Pharmacy, Tokyo Teishin Hospital, 4. Department of Hospital Pharmacy, Kyoundo Hospital, 5. Department of Development, Thinky Corporation)

[28P2-am1-116] Medical economic effect of introduction of tablet sorting equipment

○Rie Yamazaki¹, Reina Minakawa¹, Yoshie Yonemoto¹, Chihiro Ikeda¹, Hiroshi Ichimura¹, Haruka Kikuchi¹, Mai Saitou¹, Keisuke Yamada¹, Tamohiro Kida¹, Shun Hosono¹, Shino Nishi¹, Yuki Yamazaki¹ (1. Musashimurayama Hospital)

[28P2-am1-117] Use of spectral imaging techniques in the inspection for difficult to identify medicines.

○Ryo Kobayashi^1,2, Hiroyuki Tomita ³, Takatomo Watanabe ³, Hideshi Okada³, Akio Suzuki^1,2 (1. Gifu. Pharm. Univ, 2. Gifu. Univ. Hosp. Dept. Pharm., 3. Grad. Sch. Med., Gifu. Univ.)

[28P2-am1-118] Investigation of enteric capsule coating method using Eudragit L100-55

○Keiichiro Higuchi¹, Hiroko Matsui¹, Shinsuke Hara¹, Shunya Yonemura¹, Shinichiro Maeda¹, Masahiro Okuda¹ (1. Osaka University Hospital)

[28P2-am1-119] Reformulation of grinded powder from Dexamethasone tablets to glanules by planetary centrifugal mixer to mask the bitter taste and to applicate for pediatric patients

○Rie Yamauchi¹, Shuji Ohno¹, Tamaki Toshida¹, Nobuhiro Inoue¹, Hajime Kubo¹, Kazunori Asai¹ (1. Div. Pharm. Edu. Res., Hoshi Univ.)

[28P2-am1-120] Effect of Preparation Methods on the Storage Stability of a Hospital Formulation of Ulinastatin Vaginal Suppositories.

○Takanori Nakajima¹, Sana Inoue¹, Yuka Kashima¹, Hirona Ezoe¹, Yusuke Takizawa¹, Takuro Kurita¹ (1. Nihon Pharmaceutical University)

[28P2-am1-121] Development of oral mucosa adhesive film formulation containing Polaprezinc for the prevention of stomatitis

○Eriko Yamazoe¹, Takuya Ito¹, Takaaki Ito¹, Miyui Funato², Akio Suzuki², Kohei Tahara¹ (1. Gifu Pharmaceutical University, 2. Gifu University Hospital)

[28P2-am1-122] Study on stability of octreotide by mixed injection into ELNEOPA No.1 and No.2 injection (part II)

○Hirofumi Inoue¹, Takefumi Kumagai², Hiroko Shimozuru¹, Jun Yamashita¹, Naoko Narahara¹, Eiji Sato¹, Yoshitaka Kihira¹, Yoshino Fujimura¹, Takahiro Yamashita², Eijiro Kojima¹, Shojiro Ogawa¹, Yuko Date¹ (1. Fac. Pharm. Pharm. Sci., Fukuyama Univ., 2. PHARMACY Co.Ltd.)

[28P2-am1-123] EPA permeability of nasogastric feeding tubes during pediatric administration of EPA capsules by simple suspension method

○Shiro Ishida¹, Emi Yamaguchi², Shigeo Akiyama³ (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 2. Dep. Pharm., Sendai Medical Center, 3. Tokyo Univ. Sch. Pharm.)

[28P2-am1-124S] Examination of environment during aseptic preparation in clean bench by the measurement of air flow

○Mizusa Okuno¹, Seiichiro Kuroda³, Anna Kiyomi¹, Shinobu Imai⁴, Shigeo Akiyama², Yusuke Hori², Munetoshi Sugiura¹ (1. Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 2. Education Center for Experiential Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 3. Department of Pharmacy, The Institute of Medical Science Hospital, The University of Tokyo, 4. Division of Pharmacoepidemiology, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy)

[28P2-am1-125] Survey on Electrolyte Monitoring When Enteral Nutrition Drug Renwell 3 is Used

○Akiko Enomoto¹, Masayoshi Kondo¹, Kazutoshi Sugaya¹, Hisamitu Takase¹ (1. Pharm.,Tamanagayama Nippon Medical Univ Hosp.)

[28P2-am1-126] Elucidation of Main Factors Contributing to Incompatibility of Lipid Emulsions with Injections

○Tomonori Ohata¹, Misaki Oho¹, Rie Nakashima¹, Hiroyuki Tsutsumi¹, Hirohito Ikeda¹ (1. Fac. Pharm. Sci., Fukuoka Univ.)

[28P2-am1-127] Stability of Adrenaline in Equal Volume Dilution of Lidocaine Hydrochloride Injection with Adrenaline-containing Lidocaine Hydrochloride Injection.

○YASUNORI KUBO¹, Joe Yamamoto¹, Takayuki Manabe^1,2, Kuninori Iwayama^1,3, Naoya Kamiyama^1,2, Yasunori Yamashita¹, Takashi Ono¹, Masayuki Chuma¹, Yoshikazu Tasaki¹ (1. Dept. of Pharmacy and Pharmacology, Asahikawa med. Univ. Hosp., 2. CRSC, Asahikawa med. Univ. Hosp., 3. Dept. of Pharm. and Therap. Hokkaido Univ. of Sci.)

[28P2-am1-128] Study on the storage of repackaged Chinese herbal extract preparations

○Manabu Shimazaki¹, Ayano Okajima¹, Yuta Watanabe¹ (1. Fac. Pharm. Sci., Teikyo Heisei Univ.)

[28P2-am1-129] Antibiotic use and drug sensitivity are varied by initiatives for antimicrobial stewardship

○yukako hatanaka^1,2, wakae yase², hirokazu oishi², tatsuya murakami^1,2, masato fukuyama^1,2, mhidemaru matumoto^1,2, daisuke kurokawa², hisao mizutani², yuji saisho², shinitiro nakamura³ (1. Department of pharmacy,Himeji japan red cross hospital, 2. Department of infection of control, Himeji japan red cross hospital, 3. Department of internal medicine,Himeji japan red cross hospital)

[28P2-am1-130] Deep neural network for evaluating the similarity of PTP sheets

○Tomohiro Ueda¹, Yuki Kunitsu¹, Yoshito Ikeda¹, Daiki Hira^1,2, Shin-ya Morita¹ (1. Department of Pharmacy, Shiga University of Medical Science Hospital, 2. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital)

[28P2-am1-131S] Analysis of pharmaceutical care records using natural language processing system MedNER-J

○Yukiko Ohno¹, Haruki Ishikawa¹, Riri Kato¹, Minae Isawa¹, Mayumi Mochizuki¹, Tomohiro Nishiyama², Eiji Aramaki², Tohru Aomori^1,3 (1. Keio Univ. Fac. Pharm., 2. Grad. Sch. Sci. and Tech., NAIST, 3. Keio Univ. Hosp. Dep. Pharm.)

[28P2-am1-132] Efforts to promote digital transformation (DX) in drug information management

○Naohiro Ohara¹, Ryosuke Oda¹, Naotake Maruyama¹, Toshiyuki Doi¹ (1. National Hospital Organization Kyoto Medical Center)

[28P2-am1-133] An analysis of the association between DPP-4 inhibitor and angioedema, including cases where the concomitant ACE inhibitor was absent

○Katsuhiro Ohyama¹, Junichiro Shindo¹, Tomohiro Takahashi¹, Hironori Takeuchi², Yusuke Hori¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Science, 2. Tokyo Medical University Hospital)

[28P2-am1-134S] Study on the characteristics of biological products related to Infusion reaction using Japanese Adverse Drug Event Report datebase (JADER)

○Yuna Kise¹, Yusuke Tabuchi^2,1, Tomomi Sakamoto¹, Miyu Matuda¹, Masayuki Tujimoto¹, Kohshi Nishiguchi¹ (1. Kyoto Pharm. Univ., 2. Dept. of Pharm., Univ., Hosp., Kyoto Pref. Univ. of Med.,)

[28P2-am1-135] Current status and issues of MR under the popularized ICT

○Tsuyoshi Kohinata¹, Kiyoko Watanabe¹, Youhei Chikazawa¹ (1. MR Education and Accreditation Center of Japan)

[28P2-am1-136] Analysis of Precipitates Produced from Risperidone Oral Solution by Tea Catechins using Quantitative NMR

○Takeshi Goromaru¹, Yuka Murakami¹, Yuki Yagyu¹, Sakiho Saito¹, Takashi Ishizu¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University)

[28P2-am1-137] Characteristics of adverse reactions to HPV vaccine : comparison with Influenza vaccine using association analysis

○Kenji Matsuura¹, Yuichi Harano² (1. Facult. Pharm., Osaka-Ohtani Univ., 2. Facult. Pharm. Sci., Himeji Dokkyo Univ.)

[28P2-am1-138S] Systematic review on the association between falls and sleeping drugs with novel mechanism of action

○Rika Kuwabara¹, Haruki Ishikawa¹, Mayu Suzukawa¹, Minae Isawa¹, Mayumi Mochizuki¹, Tohru Aomori^1,2 (1. Keio Univ. Fac. Pharm, 2. Keio Univ. Hosp. Dep. Pharm.)

[28P2-am1-139] Exploration of Safety Information on Acute Kidney Injury Caused by Oral Drugs Using the Japanese Adverse Drug Event Report database

○Yusuke Kan^1,2, Mutsumi Hunaki¹, Yoshihiro Uesawa² (1. Nanohana Hokkaido, 2. Meiji Pharm. Univ.)

[28P2-am1-140S] Exploration of chemical structures associated with selective toxicity against cells derived from oral squamous cell carcinoma based on QSAR prediction model using machine learning.

○Hiroki Ito¹, Miku Kudou¹, Kota Kurosaki¹, Yoshihiro Uesawa¹, Hiroshi Sakagami² (1. Meiji Pharm. Univ., 2. Meikai Univ. School of Dentistry)

[28P2-am1-141] The role of pharmacists by a survey of the current status of obtaining information on Drug and health foods

○Toshiaki Nakamura¹, Akiho Nakano¹, Ryoichi Yano¹, Kaori Kadoyama¹ (1. Fac.Pharm.,Osaka Med. Pharm. Univ.)

[28P2-am1-142S] Analysis of antimicrobial agents that induce anaphylaxis based on FAERS

○Chihaya Komori¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-143S] Analysis of drugs that induce disturbances in consciousness using FAERS

○Yuna Takahashi¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-144S] Comprehensive analysis for adverse effects associated with constitutive androstane receptor (CAR) agonist activity

○Kai Kawakami¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-145] Research on information used in the development of pediatric drugs in Japan:Utilization of pharmacokinetic information

○Wakana Kuwano¹, Mika Maeda^1,2, Mami Suzuki², Michiru Ochiai³, Masako Asou⁴, Masahiro Kobayashi^1,2, Katsuya Otori^1,2, Yuuji Kumagai^5,6 (1. School of Pharmacy, Kitasato University, 2. Department of Pharmacy, Kitasato University Hospital, 3. Kitasato University Graduate School of Medical Sciences, 4. Soleil Kawasaki Medical Center for the Handicapped, 5. Kitasato Clinical Research Center, Kitasato University School of Medicine, 6. Clinical Trial Center,Kitasato University Hospital)

[28P2-am1-146S] Preliminary Study of Building an AI System for Extract Patient Statements mentioning Symptoms from the Pharmaceutical Management Records

○Reina Fujiki¹, Yukiko Ohno¹, Riri Kato¹, Tomohiro Nishiyama², Haruki Ishikawa¹, Minae Isawa¹, Mayumi Mochizuki¹, Eiji Aramaki², Tohru Aomori^1,3 (1. Keio Univ. Fac. Pharm., 2. Grad. Sch. Sci. and Tech., NAIST, 3. Keio Univ. Hosp. Dep. Pharm.)

[28P2-am1-147S] Analysis of factors associated with drug-induced lung cancer using the FAERS database

○Naoki Toyoda¹, Kota Kurosaki¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-148S] Comprehensive analysis of suppressive effects of chromone-based drugs on adverse drug reactions: Database research for drug repositioning

○Kotone Yoshino¹, Mizuho Asada¹, Hiroshi Sakagami², Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ, 2. Meikai Univ. Sch. Dent.)

[28P2-am1-149S] Analysis of biochemical factors contributing to tumor selectivity for human oral squamous cell carcinoma using chemical structures

○Miku Kudo¹, Hiroki Ito¹, Yoshihiro Uesawa¹, Hiroshi Sakagami² (1. Meiji Pharm. Univ., 2. Meikai Univ. School of Dentistry)

[28P2-am1-150S] Analysis of drug-drug interactions for peripheral neuropathy using a large-scale spontaneously reported adverse event database

○Takumi Naito¹, Kenji Onda¹, Tomoya Suzuki¹, Kenichi Suzuki¹ (1. Tokyo Univ.Pharm.Life.Sci.)

[28P2-am1-151] Alert information in package inserts regarding drug interactions mediated by CYP2D6 inhibition: current status and issues

○Toyohito Oriyama¹, Yoshiyuki Ohno¹, Naomi Nagai², Akihiro Hisaka³, Tappei Takada¹ (1. Dept. Pharm., The Univ. of Tokyo Hosp., 2. Res. Inst. Pharm. Sci., Musashino Univ., 3. Grad. Sch. Pharm. Sci., Chiba Univ.)

[28P2-am1-152S] Drug allergy characteristics of deaths following COVID-19 vaccination : a VAERS database analysis

○Yuki Yokoo¹, Masahiro Kobayashi¹, Yoshinori Tomoda¹ (1. Pharm. Sci, Kitasato Univ.)

[28P2-am1-153S] Study on lymphoproliferative disorder using a large-scale spontaneously reported adverse event database

○Tomoya Suzuki¹, Kenji Onda¹, Takumi Naito¹, Kenichi Suzuki¹ (1. Tokyo Univ. Pharm. Life. Sci.)

[28P2-am1-154S] Analysis of biochemical factors contributing to the prevention of severe cutaneous adverse reactions using FAERS and chemical structure information

○Risa Tonegawa¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-155] Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network

Ryogo Umetsu¹, Mizuki Tanaka¹, Yoko Nakayama¹, Yamato Kato¹, Natsumi Ueda¹, Yuri Nishibata¹, Shiori Hasegawa¹, Kiyoka Matsumoto¹, Noriaki Takeyama¹, ○Kazuhiro Iguchi¹, Hiroyuki Tanaka¹, Eiichi Hinoi¹, Naoki Inagaki², Masatoshi Inden¹, Yoshinori Muto³, Mitsuhiro Nakamura¹ (1. Gifu Pharm. Univ., 2. Gifu Univ. Med. Sci., 3. Gifu Univ.)

[28P2-am1-156] Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System

○Kouseki Hirade¹, Misa Naganuma², Kohei Tahara², Shiori Hasegawa², Akiho Fukuda², Misaki Inoue², Sayaka Sasaoka², Haruna Hatahira¹, Yumi Motooka², Satoshi Nakao², Ririka Mukai², Tomoaki Yoshimura³, takeshi Kato¹, Hirofumi Takeuchi², Mitsuhiro Nakamura² (1. Department of Pharmacy, Central Japan International Medical Center, 2. Gifu Pharmaceutical University, 3. Department of Pharmacy, Ogaki Municipal Hospital)

[28P2-am1-157] Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database

○Satoshi Nakao¹, Shiori Hasegawa¹, Ryogo Umetsu¹, Kazuyo Shimada¹, Ririka Mukai¹, Mizuki Tanaka¹, Kiyoka Matsumoto¹, Yu Yoshida¹, Misaki Inoue¹, Riko Satake¹, Yuri Nishibata¹, Jun Liao², Mitsuhiro Nakamura¹ (1. Gifu Pharm. Univ., 2. China Pharm. Univ.)

[28P2-am1-158] Analysis of the risk of drug-induced falls and fractures using the Drug Adverse Reaction Database (JADER)

○Nana Kojima¹, Reiko Yano¹, Yutaka Aoyagi¹, Takamasa Sakai², Fumiko Ohtsu², Nobuyuki Goto³ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Meijo University, 3. Department of Pharmacy University of Fukui Hospital)

[28P2-am1-159] Study on Interstitial pneumonia with herbal medicines, crude drugs

○Rino Tokuda¹, Reiko Yano¹, Akito Nagatsu¹, Takamasa Sakai², Fumiko Ohtsu², Nobuyuki Goto³ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Meijo University, 3. Department of Pharmacy University of Fukui Hospital)

[28P2-am1-160S] Analysis of aggression in the elderly using the Adverse Drug Reactions Database (JADER)

○Kana Mitsui¹, Rino Nagata¹, Reiko Yano¹, Yutaka Aoyagi¹, Takamasa Sakai², Fumiko Ohtsu², Nobuyuki Goto³ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Meijo University,, 3. Department of Pharmacy University of Fukui Hospital)

[28P2-am1-161S] Research on clinical and calculated dose for pediatric

○Minami Uchibori¹, Reiko Yano¹, Yutaka Aoyagi¹, Fumiko Ohtsu², Nobuyuki Goto³ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Meijo University, 3. Department of Pharmacy University of Fukui Hospital)

[28P2-am1-162] Development of a risk reduction support system for detecting adverse drug reactions (MPASS)

○Tamotsu Noguchi¹, Nobuyuki Kanno² (1. Comput. Biol., Meiji Pharm. Univ., 2. Comm. Health Care and Sci., Meiji Pharm. Univ.)

[28P2-am1-163] Practical Study of a risk reduction support system for detecting advease drug reactions(MPASS)

○Nobuyuki Kanno¹, Noguchi Tamotsu¹ (1. Meiji Pharm.Sci.Univ)

[28P2-am1-164S] Adverse Reaction Analysis of Human Papillomavirus Vaccine Using Vaccine Adverse Event Database

○Nanami Otsuka¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji. Pharm. Univ)

[28P2-am1-165S] Analysis of factors affecting drug-induced cataracts based on adverse event reporting system database

○Nao Noguchi¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-166S] Construction and evaluation of a Machine Learning prediction model based on chemical structural features of pruritus-inducing drugs

○Yuriko Nakao¹, Kota Kurosaki¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-167S] Exploring the factors that cause drug-induced pulmonary arterial hypertension using the FDA Adverse Event Reporting System database

○Honoka Nara¹, Mizuho Asada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-168S] Analysis of trends in adverse events related to drugs with xanthine skeletons using FDA Adverse Event Reporting System (FAERS) database

○Masatsugu Ogawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-169S] Analysis of drug-induced glaucoma using the Japanese Adverse Drug Event Report (JADER) database

○Ayano Kawabe¹, Yoshihiro Uesawa¹ (1. Meiji Pharm.Univ.)

[28P2-am1-170S] Analysis of NSAID-induced lower gastrointestinal tract injury using the FDA Adverse Event Reporting System database (FAERS)

○Nanako Sashida¹, Yoshihiro Uesawa¹ (1. Meiji Pharm.Univ.)

[28P2-am1-171S] Search for steroid-related drugs that inhibit multiple sclerosis using the FDA Adverse Event Reporting System database

○Shunsuke Nomoto¹, Mizuho Asada^1,2, Tkahisa Mikami³, Mitsuhiro Goda^4,5, Yuuhei Sonoda^4,5, Shimon Takahashi^4,5, Fuka Aizawa^4,5, Takahiro Niimura^4,6, Yoshito zamami⁷, Masayuki Chuma⁸, Keisuke Ishizawa^4,5,6, Yosihiro Uesawa¹ (1. Meiji Pharm. Univ., 2. Department of Pharmacy, Tokyo Medical and Dental University, 3. Department of Neurology, Tufts University School of Medicine, 4. Tokushima University Graduate School of Biomedical Sciences, 5. Department of Pharmacy, Tokushima University Hospital, 6. Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 7. Department of Pharmacy, Okayama University Hospital, 8. Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University)

[28P2-am1-172S] Analysis of COVID-19 vaccine by using Vaccine Adverse Event Reporting System (VAERS).

○Ami Ogata¹, Yoshihiro Uesawa¹ (1. Meiji. Pharm. Univ)

[28P2-am1-173S] Analysis of biochemical factors associated with the effects of steroids on drug-induced liver injury using the Japanese Adverse Drug Event Report database

○Yuha Shimakawa¹, Yoshihiro Uesawa¹ (1. Meiji. Pharm. Univ.)

[28P2-am1-174S] Analysis of anticancer drugs that induce edema based on the FDA Adverse Event Reporting System (FAERS) database

○Yoshiki Takizawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[28P2-am1-175S] Analysis of trends in the occurrence of adverse reactions to topical steroids using JADER, a Japanese database of spontaneous adverse event reporting of pharmaceuticals

○Saki Takei¹, Yoshihiro Uesawa¹ (1. Meiji. Pharm. Univ.)

[28P2-am1-176S] Analysis of drug-induced sleep disorder based on FAERS

○Naoki Harada¹, Yoshihiro Uesawa¹ (1. Meiji Pharm.Univ.)

[28P2-am1-177S] Analysis of side effects caused by infants with atrial septal defect based on FAERS

○Noa Nishitani¹, Yoichi Ishikawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

Session information

[28P2-am1] Clinical Pharmacy 4

Authentication